Tumefactive multiple sclerosis and fingolimod

J Neurol Sci. 2014 Sep 15;344(1-2):1-2. doi: 10.1016/j.jns.2014.06.022. Epub 2014 Jun 24.

Authors

Jesus Lovera¹, Nicole Villemarette-Pittman²

Affiliations

¹ Department of Neurology, Louisiana State University Health Sciences Center-New Orleans, 1542 Tulane Avenue, Rm 718A, New Orleans, LA 70112, United States. Electronic address: jlover@lsuhsc.edu.
² Department of Neurology, Louisiana State University Health Sciences Center-New Orleans, 1542 Tulane Avenue, Rm 718A, New Orleans, LA 70112, United States.

PMID: 24993468
DOI: 10.1016/j.jns.2014.06.022

No abstract available

Publication types

Editorial
Comment

MeSH terms

Brain Injuries / chemically induced*
Encephalitis / chemically induced*
Female
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents / adverse effects*
Multiple Sclerosis / drug therapy*
Occipital Lobe / pathology*
Propylene Glycols / adverse effects*
Sphingosine / adverse effects
Sphingosine / analogs & derivatives*

Substances

Immunosuppressive Agents
Propylene Glycols
Fingolimod Hydrochloride
Sphingosine